Target-based in-silico screening of basil polysaccharides against different epigenetic targets responsible for breast cancer

References

• Ezzati M, Yousefi B, Velaei K, et al. A review on anti-cancer properties of quercetin in breast cancer. Life Sci. 2020;248:117463.
   PubMed Web of Science ®Google Scholar
• Nanda R, Chow LQ, Dees EC, et al. Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study. J Clin Oncol. 2016;34(21):2460–2467.
   PubMed Web of Science ®Google Scholar
• Peart O. Metastatic breast cancer. Radiologic Technol. 2017;88(5):519M–539M.
   PubMed Web of Science ®Google Scholar
• Hinshelwood RA, Clark SJ. Breast cancer epigenetics: normal human mammary epithelial cells as a model system. J Med Chem. 2008;86(12):1315–1328.
   Google Scholar
• Villanueva L, Álvarez-Errico D, Esteller M. The contribution of epigenetics to cancer immunotherapy. Trends Immunol. 2020;41(8):676–691.
   PubMed Web of Science ®Google Scholar
• Giri AK, Aittokallio T. DNMT inhibitors increase methylation in the cancer genome. Front Pharmacol. 2019;10(385):385.
   PubMedGoogle Scholar
• Nervi C, De Marinis E, Codacci-Pisanelli G. Epigenetic treatment of solid tumours: a review of clinical trials. Clin Epigenetics. 2015;7:127.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79(3):629–661.
   PubMed Web of Science ®Google Scholar
• Atanasov AG, Zotchev SB, Dirsch VM, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discovery. 2021;20(3):200–216.
   PubMed Web of Science ®Google Scholar
• Feng B, Zhu Y, Su Z, et al. Basil polysaccharide attenuates hepatocellular carcinoma metastasis in rat by suppressing H3K9me2 histone methylation under hepatic artery ligation-induced hypoxia. Int J Biol Macromol. 2018;107(Pt B):2171–2179.
   PubMedGoogle Scholar
• Lv J, Shao Q, Wang H, et al. Effects and mechanisms of curcumin and basil polysaccharide on the invasion of SKOV3 cells and dendritic cells. Mol Med Rep. 2013;8(5):1580–1586.
   PubMed Web of Science ®Google Scholar
• Moghimi M, Rashidian S, Khosravian F, et al. Basil and dracocephalum kotschyi alcoholic extracts affect BCL2 expression and HepG2 cell proliferation. Res Mol Med. 2019;7(1):32–42.
   Google Scholar
• Kim H, Ramirez CN, Su Z-Y, et al. Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells. J Nutr Biochem. 2016;33:54–62.
   PubMed Web of Science ®Google Scholar
• Alkhateeb MA, Al-Otaibi WR, AlGabbani Q, et al. Low-temperature extracts of purple blossoms of basil (Ocimum basilicum L.) intervened mitochondrial translocation contributes prompted apoptosis in human breast cancer cells. Biol Res. 2021;54(1):2–10.
   PubMed Web of Science ®Google Scholar
• Shukla S, Penta D, Mondal P, et al. Epigenetics of breast cancer: clinical status of epi-drugs and phytochemicals. Adv Exp Med Biol. 2019;1152:293–310.
   Google Scholar
• Zucchetti B, Shimada AK, Katz A, et al. The role of histone deacetylase inhibitors in metastatic breast cancer. Breast. 2019;43:130–134.
   PubMed Web of Science ®Google Scholar
• Zhuang J, Huo Q, Yang F, et al. Perspectives on the role of histone modification in breast cancer progression and the advanced technological tools to study epigenetic determinants of metastasis. Front Genet. 2020;11(603552):603552.
   PubMedGoogle Scholar
• Opo FADM, Rahman MM, Ahammad F, et al. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting. XIAP Protein. Sci Rep. 2021;11(1):1–17.
   Google Scholar
• Irwin JJ, Shoichet BK. ZINC: a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45(1):177–182.
   PubMed Web of Science ®Google Scholar
• Burana-Osot J, Pattanapanyasat K, Soonthornchareonnon N, et al. Characterisation and immuno-stimulating activity of polysaccharides from Thai medicinal plants. Nat Prod Res. 2010;24(15):1403–1412.
   PubMed Web of Science ®Google Scholar
• O'Boyle NM, Banck M, James CA, et al. Open babel: an open chemical toolbox. J Cheminf. 2011;3(1):1–14.
   PubMed Web of Science ®Google Scholar
• Huang M, Zhang J, Yan C, et al. Small molecule HDAC inhibitors: promising agents for breast cancer treatment. Bioorg Chem. 2019;91:103184.
   PubMed Web of Science ®Google Scholar
• Novotny-Diermayr V, Sangthongpitag K, Hu CY, et al. SB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancer. Mol Cancer Ther. 2010;9(3):642–652.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Redvers RP, Chi LH, et al. Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis. Dis Models Mech. 2018;11(7):DMM034850.
   PubMed Web of Science ®Google Scholar
• Chen J, Li N, Liu B, et al. Pracinostat (SB939): a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways. Life Sci. 2020;248:117469.
   PubMed Web of Science ®Google Scholar
• Torres RG, Casanova L, Carvalho J, et al. Ocimum basilicum but not ocimum gratissimum present cytotoxic effects on human breast cancer cell line MCF-7, inducing apoptosis and triggering mTOR/akt/p70S6K pathway. J Bioenerg Biomembr. 2018;50(2):93–105.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liu X, Xue J, et al. Discovery of peptide boronate derivatives as histone deacetylase and proteasome dual inhibitors for overcoming bortezomib resistance of multiple myeloma. J Med Chem. 2020;63(9):4701–4715.
   PubMed Web of Science ®Google Scholar
• Brunsteiner M, Petukhov PA. Insights from comprehensive multiple receptor docking to HDAC8. J Mol Model. 2012;18(8):3927–3939.
   PubMed Web of Science ®Google Scholar
• Harding RJ, Ferreira de Freitas R, Collins P, et al. Small molecule antagonists of the interaction between the histone deacetylase 6 zinc-finger domain and ubiquitin. J Med Chem. 2017;60(21):9090–9096.
   PubMed Web of Science ®Google Scholar
• Kandakatla N, Ramakrishnan G. Ligand based pharmacophore modeling and virtual screening studies to design novel HDAC2 inhibitors. Adv Bioinformatics. 2014;2014:812148.
   PubMedGoogle Scholar
• Micheletti G, Calonghi N, Farruggia G, et al. Synthesis of novel structural hybrids between aza-heterocycles and azelaic acid moiety with a specific activity on osteosarcoma cells. Molecules. 2020;25(2):404.
   Web of Science ®Google Scholar
• Punjabi M, Bharadvaja N, Sachdev A, et al. Molecular characterization, modeling, and docking analysis of late phytic acid biosynthesis pathway gene, inositol polyphosphate 6-/3-/5-kinase: a potential candidate for developing low phytate crops. 3 Biotech. 2018;8(8):1–20.
   PubMedGoogle Scholar
• Venturelli S, Berger A, Böcker A, et al. Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells. PLOS One. 2013;8(8):e73097.
   PubMed Web of Science ®Google Scholar
• Wu F, Hua Y, Kaochar S, et al. Discovery, structure-activity relationship, and biological activity of histone-competitive inhibitors of histone acetyltransferases P300/CBP. J Med Chem. 2020;63(9):4716–4731.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sanner MF. AutoDock CrankPep: combining folding and docking to predict protein-peptide complexes. Bioinformatics. 2019;35(24):5121–5127.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.
   PubMed Web of Science ®Google Scholar
• Gupta P, Garg P, Roy N. Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors. Mol Divers. 2011;15(3):733–750.
   PubMed Web of Science ®Google Scholar
• Watson PJ, Millard CJ, Riley AM, et al. Insights into the activation mechanism of class I HDAC complexes by inositol phosphates. Nat Commun. 2016;7(1):1–13.
   Google Scholar
• Bressi JC, Jennings AJ, Skene R, et al. Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides. Bioorg Med Chem Lett. 2010;20(10):3142–3145.
   PubMed Web of Science ®Google Scholar
• Bottomley MJ, Surdo PL, Di Giovine P, et al. Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain. J Biol Chem. 2008;283(39):26694–26704.
   PubMed Web of Science ®Google Scholar
• Magudeeswaran S, Poomani K. Binding mechanism, conformation, and stability of diflunisal and mycophenolic acid with p300 HAT enzyme using molecular dynamics simulation and binding free energy analysis. Med Chem Res. 2020;29(3):504–518.
   Web of Science ®Google Scholar
• Naidoo D, Roy A, Kar P, et al. Cyanobacterial metabolites as promising drug leads against the mpro and PLpro of SARS-CoV-2: an in silico analysis. J Biomol Struct Dyn. 2021;39(16):6218–6230.
   PubMed Web of Science ®Google Scholar